雜志介紹

Phytochemistry Letters雜志介紹

《Phytochemistry Letters》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱植物化學(xué)快報(bào)，本刊主要出版、報(bào)道生物學(xué)-CHEMISTRY, MEDICINAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.3，最新CiteScore 指數(shù)為3。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Caffeoyl esters from Aruncus sylvester and their improvement in movement disorder of MPTP-induced zebrafish embryos

  Author: Li, Jiaoyang; Peng, Rui; Zhu, Yi; Pang, Meijun; Su, Yanfang

• New cinnamic acid derivatives with potential neuroprotective activities from the stems of Melicope ptelefolia

  Author: Wu, Shou-Yuan; Chen, Zi-Ming; Zhou, Zhong-Liu; Huang, Guo-Ling; Zhou, Qi; Xi, Yan-Jie

• Two new tetrahydroisoquinoline alkaloids from Portulaca oleracea

  Author: Tang, Kai-Jun; Chen, Yu; Li, Jing; Tao, Xu; Yang, Lu-Ping; Jin, Tian-Yun; Zhu, Jia-Shun; Zhao, Yu; Shen, Tao; Wang, Xiao-Ning; Ren, Dong-Mei; Xiang, Lan

• Four new glycosides from Gerbera piloselloides

  Author: Gao, Ha; Zhao, Chen-Xu; Luo, Xin-Yao; Li, Jing-Rong; Ye, Xiao-Chuan; Zhang, Tao; Zou, Zhong-Mei

英文介紹

Phytochemistry Letters雜志英文介紹

Phytochemistry Letters invites rapid communications on all aspects of natural product research including:

? Structural elucidation of natural products

? Analytical evaluation of herbal medicines

? Clinical efficacy, safety and pharmacovigilance of herbal medicines

? Natural product biosynthesis

? Natural product synthesis and chemical modification

? Natural product metabolism

? Chemical ecology

? Biotechnology

? Bioassay-guided isolation

? Pharmacognosy

? Pharmacology of natural products

? Metabolomics

? Ethnobotany and traditional usage

? Genetics of natural products

Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.